Navigation Links
UBM Medica's Musculoskeletal Network Highlights Changing Rheumatologic Landscape
Date:10/26/2011

NORWALK, Conn., Oct. 26, 2011 /PRNewswire-iReach/ -- UBM Medica today announced that Musculoskeletal Network (www.MusculoskeletalNetwork.com) now features content dedicated to the latest developments in the diagnosis and management of rheumatoid arthritis and other major rheumatologic diseases.

(Photo:  http://photos.prnewswire.com/prnh/20111026/CG93984)

Dramatic changes in recent years have altered the landscape of rheumatology and the quality of care provided for patients with these disorders. Rheumatologists and primary care physicians—who encounter rheumatologic diseases more than any other kind of condition in daily practice—often struggle to keep up with the latest advances. These articles provide the practical, current information they need to achieve the best outcomes.

The collection of Musculoskeletal Network articles includes:

• "Rheumatoid Arthritis: Current Diagnosis and Treatment Practices" by Kerry A. Wright, MBBS and Eric L. Matteson, MD, MPH, the Mayo Clinic College of Medicine. Because clinical outcomes are now known to improve with earlier treatment, identifying patients at high risk has become important in guiding therapy. The authors provide an overview of new classification criteria and the latest practices.

• "Combination Pharmacological Management of Fibromyalgia" by Chad S. Boomershine, MD, PhD, Vanderbilt University. A symptom-based approach has been recommended that uses several pharmacological agents to manage various symptoms.

• "Current Approaches to Pain Management for Patients With Osteoarthritis" by Richard S. Panush, MD and associates, Keck School of Medicine, University of Southern California. A principle- and evidence-based approach to treatment has been effective for most patients, providing comfort, reducing disability, and improving quality of life.

• "Diagnosis and Management of Gout in 2011" by N. Lawrence Edwards, MD and colleagues, University of Florida College of Medicine. Hyperuricemia and gout have increased markedly in prevalence and clinical complexity. More than ever, early and accurate diagnosis and disease management are essential.

• "Managing Systemic Sclerosis and Its Complications" by Monique Hinchcliff, MD and John Varga, MD, Feinberg School of Medicine, Northwestern University. The condition has diverse clinical manifestations and mimics, but many treatment strategies are highly effective for managing the complications.

"Musculoskeletal Network is building a comprehensive resource for specialist and generalist physicians who are dedicated to improving rheumatologic care," said Editorial Director Leo Robert. "We're excited to be adding these valuable contributions from leaders in their respective disciplines."

About UBM Medica

Addressing today's healthcare information needs, UBM Medica, a division of UBM plc (UBM.L), delivers strategic, integrated communications solutions and comprehensive reach—online, in print, live, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, drug databases, data services, live events, and other valuable resources, UBM Medica also delivers comprehensive communication solutions for the pharmaceutical and related industries. US websites include PsychiatricTimes.com, CancerNetwork.com, DiagnosticImaging.com, ConsultantLive.com, OBGYN.net, PhysiciansPractice.com and SearchMedica.com.  Employing more than 1,400 people with offices in 29 countries, UBM Medica is headquartered in London.  For more information, visit http://www.ubmmedica.com/.

Media Contact: Amy Erdman, UBM Medica, 203-523-7041, amy.erdman@ubm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE UBM Medica
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
2. Symmetry Medical to Present at Canaccord Genuitys Musculoskeletal Conference
3. FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain
4. FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain
5. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
6. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
7. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
8. Clarient Joins the HistoRx® Clinical Trials Network: First Commercial Lab to Provide Aqua® Technology for Clinical Trials
9. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
10. ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S.
11. Philips Teams up With Integrated Oncology Network, Reinforcing Its Commitment to the Future of Cancer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... NEW YORK , March 29, 2017 ... ... society and the public safety in regulating marijuana, but economic ... revenues, job creation, and reduced law enforcement costs. However, to ... like those provided by SinglePoint, Inc. (OTC: SING) ( SING ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... The global emerging cancer diagnostics market is ... 2016 to 2023 and reach a figure of $6.34 ... a chronic disease and is affecting a huge population. ... This report is focused on emerging cancer diagnostics market ... propelled due to factors such as: increasing number of ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a ... treatment and accepting new pediatric patients, with or without a referral. Dr. Cotey knows ... a better orthodontic outcome and experience. When patients receive early treatment, they may achieve ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical cannabis ... the company’s executive management team with prominent executives from both inside and outside the ... Operating Officer, Ted Dumbauld , who has more than twenty years of business ...
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... treatment of a growing number of cancers and is touted to be the next ... of treatment, thus far, has been in the form of immune checkpoint inhibitors such ...
(Date:3/29/2017)... ... , ... The Wharton School of the University of Pennsylvania is pleased to ... $10 million gift to establish the Ken Moelis and Julie Taffet Moelis Advance ... Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions ...
Breaking Medicine News(10 mins):